These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 34096874)

  • 1. Why #WeAreNotWaiting-Motivations and Self-Reported Outcomes Among Users of Open-source Automated Insulin Delivery Systems: Multinational Survey.
    Braune K; Gajewska KA; Thieffry A; Lewis DM; Froment T; O'Donnell S; Speight J; Hendrieckx C; Schipp J; Skinner T; Langstrup H; Tappe A; Raile K; Cleal B
    J Med Internet Res; 2021 Jun; 23(6):e25409. PubMed ID: 34096874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emotional and Physical Health Impact in Children and Adolescents and Their Caregivers Using Open-source Automated Insulin Delivery: Qualitative Analysis of Lived Experiences.
    Braune K; Krug N; Knoll C; Ballhausen H; Thieffry A; Chen Y; O'Donnell S; Raile K; Cleal B
    J Med Internet Res; 2022 Jul; 24(7):e37120. PubMed ID: 35834298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-World Use of Do-It-Yourself Artificial Pancreas Systems in Children and Adolescents With Type 1 Diabetes: Online Survey and Analysis of Self-Reported Clinical Outcomes.
    Braune K; O'Donnell S; Cleal B; Lewis D; Tappe A; Willaing I; Hauck B; Raile K
    JMIR Mhealth Uhealth; 2019 Jul; 7(7):e14087. PubMed ID: 31364599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychosocial Outcomes Among Users and Nonusers of Open-Source Automated Insulin Delivery Systems: Multinational Survey of Adults With Type 1 Diabetes.
    Schipp J; Hendrieckx C; Braune K; Knoll C; O'Donnell S; Ballhausen H; Cleal B; Wäldchen M; Lewis DM; Gajewska KA; Skinner TC; Speight J
    J Med Internet Res; 2023 Dec; 25():e44002. PubMed ID: 38096018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, Safety, and Metabolic Control Among Danish Children and Adolescents with Type 1 Diabetes Using Open-Source Automated Insulin Delivery Systems.
    Fagerberg AR; Borch L; Kristensen K; Hjelle JS
    Diabetes Technol Ther; 2024 May; 26(5):287-297. PubMed ID: 38386435
    [No Abstract]   [Full Text] [Related]  

  • 6. Barriers to Uptake of Open-Source Automated Insulin Delivery Systems: Analysis of Socioeconomic Factors and Perceived Challenges of Caregivers of Children and Adolescents With Type 1 Diabetes From the OPEN Survey.
    Huhndt A; Chen Y; O'Donnell S; Cooper D; Ballhausen H; Gajewska KA; Froment T; Wäldchen M; Lewis DM; Raile K; Skinner TC; Braune K
    Front Clin Diabetes Healthc; 2022; 3():876511. PubMed ID: 36992765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical Guidance on Open Source and Commercial Automated Insulin Delivery Systems: A Guide for Healthcare Professionals Supporting People with Insulin-Requiring Diabetes.
    Lewis DM; Hussain S
    Diabetes Ther; 2022 Sep; 13(9):1683-1699. PubMed ID: 35913655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers to uptake of Open-Source automated insulin delivery Systems: Analysis of socioeconomic factors and perceived challenges of adults with type 1 diabetes from the OPEN survey.
    O'Donnell S; Cooper D; Chen Y; Ballhausen H; Lewis DM; Froment T; Anna Gajewska K; Tappe A; Skinner T; Cleal B; Braune K
    Diabetes Res Clin Pract; 2023 Mar; 197():110235. PubMed ID: 36581143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life and psychological well-being among children and adolescents with diabetes and their caregivers using open-source automated insulin delivery systems: Findings from a multinational survey.
    Knoll C; Schipp J; O'Donnell S; Wäldchen M; Ballhausen H; Cleal B; Gajewska KA; Raile K; Skinner T; Braune K
    Diabetes Res Clin Pract; 2023 Feb; 196():110153. PubMed ID: 36423699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A real-world study of user characteristics, safety and efficacy of open-source closed-loop systems and Medtronic 670G.
    Jeyaventhan R; Gallen G; Choudhary P; Hussain S
    Diabetes Obes Metab; 2021 Aug; 23(8):1989-1994. PubMed ID: 33999488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended Use of an Open-Source Automated Insulin Delivery System in Children and Adults with Type 1 Diabetes: The 24-Week Continuation Phase Following the CREATE Randomized Controlled Trial.
    Burnside MJ; Lewis DM; Crocket HR; Meier RA; Williman JA; Sanders OJ; Jefferies CA; Faherty AM; Paul RG; Lever CS; Price SKJ; Frewen CM; Jones SD; Gunn TC; Lampey C; Wheeler BJ; de Bock MI
    Diabetes Technol Ther; 2023 Apr; 25(4):250-259. PubMed ID: 36763345
    [No Abstract]   [Full Text] [Related]  

  • 12. Open-source automated insulin delivery systems (OS-AIDs) in a pediatric population with type 1 diabetes in a real-life setting: the AWeSoMe study group experience.
    Nir J; Rachmiel M; Fraser A; Lebenthal Y; Brener A; Pinhas-Hamiel O; Haim A; Stern E; Levek N; Ben-Ari T; Landau Z
    Endocrine; 2023 Aug; 81(2):262-269. PubMed ID: 37222881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world evidence on clinical outcomes of people with type 1 diabetes using open-source and commercial automated insulin dosing systems: A systematic review.
    Knoll C; Peacock S; Wäldchen M; Cooper D; Aulakh SK; Raile K; Hussain S; Braune K
    Diabet Med; 2022 May; 39(5):e14741. PubMed ID: 34773301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do-It-Yourself (DIY) Artificial Pancreas Systems for Type 1 Diabetes: Perspectives of Two Adult Users, Parent of a User and Healthcare Professionals.
    Ahmed SH; Ewins DL; Bridges J; Timmis A; Payne N; Mooney C; MacGregor C
    Adv Ther; 2020 Sep; 37(9):3929-3941. PubMed ID: 32696329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open-source Web Portal for Managing Self-reported Data and Real-world Data Donation in Diabetes Research: Platform Feasibility Study.
    Cooper D; Ubben T; Knoll C; Ballhausen H; O'Donnell S; Braune K; Lewis D
    JMIR Diabetes; 2022 Mar; 7(1):e33213. PubMed ID: 35357312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of predicted low suspend pump treatment on improving glycaemic control and quality of sleep in children with type 1 diabetes and their caregivers: the QUEST randomized crossover study.
    Schierloh U; Aguayo GA; Fichelle M; De Melo Dias C; Celebic A; Vaillant M; Barnard K; Cohen O; de Beaufort C
    Trials; 2018 Dec; 19(1):665. PubMed ID: 30509293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-World Use and Self-Reported Health Outcomes of a Patient-Designed Do-it-Yourself Mobile Technology System for Diabetes: Lessons for Mobile Health.
    Lee JM; Newman MW; Gebremariam A; Choi P; Lewis D; Nordgren W; Costik J; Wedding J; West B; Gilby NB; Hannemann C; Pasek J; Garrity A; Hirschfeld E
    Diabetes Technol Ther; 2017 Apr; 19(4):209-219. PubMed ID: 28245152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence on User-Led Innovation in Diabetes Technology (The OPEN Project): Protocol for a Mixed Methods Study.
    O'Donnell S; Lewis D; Marchante Fernández M; Wäldchen M; Cleal B; Skinner T; Raile K; Tappe A; Ubben T; Willaing I; Hauck B; Wolf S; Braune K
    JMIR Res Protoc; 2019 Nov; 8(11):e15368. PubMed ID: 31742563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point-Counterpoint: The Need for Do-It-Yourself (DIY) Open Source (OS) AID Systems in Type 1 Diabetes Management.
    Forlenza GP; Tabatabai I; Lewis DM
    Diabetes Technol Ther; 2024 Oct; 26(10):689-699. PubMed ID: 38669472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do-It-Yourself and Commercial Automated Insulin Delivery Systems in Type 1 Diabetes: An Uncertain Area for Canadian Health-care Providers.
    Morrison AE; Senior PA; Bubela T; Farnsworth K; Witteman HO; Lam A
    Can J Diabetes; 2022 Dec; 46(8):863-870. PubMed ID: 35945126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.